CDK
| CATALOG NO | PRODUCT NAME | CAS | PURITY |
|---|---|---|---|
| 52105 | SNS-032 ( BMS-387032 ) SNS-032 has firstly been described as a selective inhibitor ofCDK2withIC50of 48 nM an | 345627-80-7 | 98% |
| 181241 | CYC065 CYC065是一种具有口服生物利用率的细胞周期蛋白依赖性激酶2、5和 | 1070790-89-4 | >98% |
| 181242 | BAY1143572 Atuveciclib，也被称为BAY1143572，是一种具有高度选择性、有效和口服 | 1414943-88-6 | >98% |
| 184172 | THZ531 THZ531 is a covalent CDK12 and CDK13 covalent inhibitor. Cyclin-dependent kinases 12 | 1702809-17-3 | >98% |
| 184286 | PHA-767491 HCl PHA-767491, also known as CAY10572, is a potent, ATP-competitive dual cdc7/cdk9 inhib | 942425-68-5 | >98% |
| 18574 | SEL120-34A HCl SEL120-34A is a potent and selective CDK8 inhibitor active in AML cells with high lev | 1609452-30-3 | >98% |
| 185235 | Trilaciclib (G1T28) TRILACICLIB (G1T28), A HIGHLY POTENT, TRANSIENT CDK 4/6 INHIBITOR WITHIC50s OF 1 nM A | 1374743-00-6 | >98% |
| 181152 | MBQ-167 MBQ-167 is a potent, dual Rac/Cdc42 inhibitor with IC50 of 103/78 nM, respectively, i | 2097938-73-1 | >98% |
| 1811151 | R547 R547 is orally bioavailable diaminopyrimidine cyclin-dependent kinase inhibitor (CDKI | 741713-40-6 | >98% |
| 191145 | PF-06873600 PF-06873600 is an orally bioavailable, cyclin-dependent kinase (CDK) inhibitor, with | 2185857-97-8 | >98% |
| 191212 | AZD4573 free base AZD-4573 is a selective, short-acting inhibitor of the serine/threonine cyclin-depend | 2057509-72-3 | >98% |
| 192252 | THZ2 THZ2, an analog of THZ1, with the potential to treat Triple-negative breast cancer (T | 1604810-84-5 | >98% |